Comparative Proteomic Analyses of Synovial Fluids and Serums from Rheumatoid Arthritis Patients |
Noh, Ran
(Medical Proteomics Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB))
Park, Sung Goo (Medical Proteomics Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)) Ju, Ji Hyeon (Rheumatism Research Center, Catholic Research Institute of Medical Science, Catholic University of Korea) Chi, Seung-Wook (Medical Proteomics Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)) Kim, Sunhong (Medical Proteomics Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)) Lee, Chong-Kil (Department of Pharmacy, Chungbuk National University) Kim, Jeong-Hoon (Medical Proteomics Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)) Park, Byoung Chul (Medical Proteomics Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)) |
1 | van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ. 2002. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res. 4: 87-93. |
2 | van Venrooij WJ, van Beers JJ, Pruijn GJ. 2008. Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Ann. NY Acad. Sci. 1143: 268-285. DOI ScienceOn |
3 | Vossenaar ER, van Venrooij WJ. 2004. Anti-CCP antibodies, a highly specific marker for (early) rheumatoid arthritis. Clin. Appl. Immunol. Rev. 4: 239-262. DOI ScienceOn |
4 | Willemze A, Toes RE, Huizinga TW, Trouw LA. 2012. New biomarkers in rheumatoid arthritis. Neth. J. Med. 70: 392-399 |
5 | McInnes IB, Schett G. 2011. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365: 2205-2219. DOI ScienceOn |
6 | Miyake K, Nishida K, Kadota Y, Yamasaki H, Nasu T, Saitou D, et al. 2009. Inflammatory cytokine-induced expression of vasohibin-1 by rheumatoid synovial fibroblasts. Acta Med. Okayama 63: 349-358. |
7 | Purcell AW, Elliott T. 2008. Molecular machinations of the MHC-I peptide loading complex. Curr. Opin. Immunol. 20: 75-81. DOI ScienceOn |
8 | Sato Y. 2010. The vasohibin family. Pharmaceuticals 3: 433-440. DOI |
9 | Sato Y, Sonoda H. 2007. The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 27: 37-41. DOI ScienceOn |
10 | Silman A, Pearson JE. 2002. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 4(Suppl 3): S265-S272. DOI |
11 | Sinz A, Bantscheff M, Mikkat S, Ringel B, Drynda S, Kekow J, et al. 2002. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis 23: 3445-3456. DOI ScienceOn |
12 | Steiner G, Smolen J. 2002. Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res. 4(Suppl 2): S1-S5. DOI |
13 | Suzuki A, Yamada R, Yamamoto K. 2007. Citrullination by peptidylarginine deiminase in rheumatoid arthritis. Ann. NY Acad. Sci. 1108: 323-339. DOI ScienceOn |
14 | Tanaka Y, Matsumoto I, Iwanami K, Inoue A, Minami R, Umeda N, et al. 2012. Six-transmembrane epithelial antigen of prostate 4 (STEAP4) is a tumor necrosis factor alphainduced protein that regulates IL-6, IL-8, and cell proliferation in synovium from patients with rheumatoid arthritis. Mod. Rheumatol. 22: 128-136. DOI |
15 | Thibodeau J, Bourgeois-Daigneault MC, Lapointe R. 2012. Targeting the MHC class II antigen presentation pathway in cancer immunotherapy. Oncoimmunology 1: 908-916. DOI |
16 | Firestein GS. 2003. Evolving concepts of rheumatoid arthritis. Nature 423: 356-361. DOI ScienceOn |
17 | Gobezie R, Kho A, Krastins B, Sarracino DA, Thornhill TS, Chase M, et al. 2007. High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res. Ther. 9: R36. DOI ScienceOn |
18 | Hansen TH, Bouvier M. 2009. MHC class I antigen presentation: learning from viral evasion strategies. Nat. Rev. Immunol. 9: 503-513. DOI ScienceOn |
19 | Hewitt EW. 2003. The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology 110: 163-169. DOI |
20 | Inoue A, Matsumoto I, Tanaka Y, Iwanami K, Kanamori A, Ochiai N, et al. 2009. Tumor necrosis factor alpha-induced adipose-related protein expression in experimental arthritis and in rheumatoid arthritis. Arthritis Res. Ther. 11: R118. DOI ScienceOn |
21 | Klareskog L, Rönnelid J, Lundberg K, Padyukov L, Alfredsson L. 2008. Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol. 26: 651-675. DOI ScienceOn |
22 | Liao J, Ip WS, Cheung KY, Wan WM, Cautherley GW, Cai X, et al. 2011. Diagnostic utility of an anti-CCP point-of-care immunotest in Chinese patients with rheumatoid arthritis. Clin. Chim. Acta 412: 778-781. DOI ScienceOn |
23 | Margaretten M, Julian L, Katz P, Yelin E. 2011. Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int. J. Clin. Rheumtol. 6: 617-623. DOI |
24 | Mateos J, Lourido L, Fernandez-Puente P, Calamia V, Fernandez-Lopez C, Oreiro N, et al. 2012. Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF/TOF. J. Proteomics 75: 2869-2878. DOI ScienceOn |
25 | Castellino F, Zhong G, Germain RN. 1997. Antigen presentation by MHC class II molecules: invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture. Hum. Immunol. 54: 159-169. DOI ScienceOn |
26 | Egerer K, Feist E, Burmester GR. 2009. The serological diagnosis of rheumatoid arthritis. Dtsch. Arztebl. Int. 106: 159-163. |
27 | MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, Silman AJ. 2000. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 43: 30-37. DOI ScienceOn |